Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
Автори: | , , , , , , , , , , |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Oxford University Press
2022
|
Резюме: |
---|